Ebos GroupASX:EBO +0.30%77 FCF Margin % is 0.18% as of Dec. 2025, which is 92% below its 10-year median of 2.14. GuruFocus rates ASX:EBO with a GF Score™ of 77/100 and a GF Value™ of A$31.49 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 118 Medical Distribution companies, Ebos Group ranks better than 55.93% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Ebos Group's Free Cash Flow for the
six
months ended in Dec. 2025 was A$12 Mil. Ebos Group's Revenue for the
six
months ended in Dec. 2025 was A$6,828 Mil. Therefore, Ebos Group's FCF Margin % for the quarter that ended in Dec. 2025 was 0.18%.
The historical rank and industry rank for Ebos Group's FCF Margin % or its related term are showing as below:
ASX:EBO'
s FCF Margin % Range Over the Past 10 Years
Min: 1.22 Med: 2.14 Max: 3
Current: 1.79
During the past 13 years, the highest FCF Margin % of Ebos Group was 3.00%. The lowest was 1.22%. And the median was 2.14%.
ASX:EBO's FCF Margin % is ranked better than 55.93% of 118
companies
in the Medical Distribution industry
Industry Median: 1.06
vs ASX:EBO: 1.79
Ebos Group FCF Margin % Related Terms
Ebos Group FCF Margin % Historical Data
* Premium members only.
The historical data trend for Ebos Group's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Ebos Group's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ebos Group FCF Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Ebos Group's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Ebos Group's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ebos Group (ASX:EBO) has a FCF Margin % of 0.18% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Ebos Group and its competitors. This is 92% below median its historical median of 2.14. Over the past decade, Ebos Group's FCF Margin % has ranged from 1.22 to 3.00. According to the industry distribution chart, Ebos Group ranks #52 out of 118 companies in the Medical Distribution industry, placing it in the top 44.1%.
Is Ebos Group's FCF Margin % too high?
Ebos Group's current FCF Margin % of 0.18% is 92% below median its 10-year median of 2.14. Over the past 10 years, this metric has ranged from a low of 1.22 to a high of 3.00. The Medical Distribution industry median FCF Margin % is 1.06. Ebos Group's value of 0.18% is 83% below this industry median. Based on the distribution chart, Ebos Group ranks #52 out of 118 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Ebos Group has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ebos Group's FCF Margin % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Ebos Group ranks #52 out of 118 companies for FCF Margin %. This puts Ebos Group in the upper half of its industry. The industry median FCF Margin % is 1.06. Ebos Group's value of 0.18% is 83% below this benchmark. Historically, Ebos Group's own FCF Margin % has ranged from 1.22 to 3.00 over the past decade. While the company's 10-year median is 2.14 vs. the industry median of 1.06, Ebos Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Distribution company?
The median FCF Margin % among Medical Distribution companies is 1.06, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ebos Group's current FCF Margin % of 0.18% is 83% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Ebos Group and its competitors. For the Medical Distribution industry, the median FCF Margin % is 1.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ebos Group's current FCF Margin % is 0.18%, which is 92% below median its own 10-year median of 2.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ebos Group stock overvalued right now?
Based on GuruFocus' analysis, Ebos Group (ASX:EBO) is currently considered Significantly Undervalued. The stock's GF Value™ is A$31.49, compared to a current price of A$16.76 — trading 46.8% below its estimated fair value. The current FCF Margin % is 0.18%, which is 92% below median its 10-year median of 2.14 and 83% below the Medical Distribution industry median of 1.06. Ebos Group's overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Ebos Group (ASX:EBO), the current FCF Margin % is 0.18% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ebos Group (ASX:EBO) Overvalued in 2026?
Based on GuruFocus' analysis, Ebos Group stock appears to be undervalued.
The current stock price of A$16.76 is trading 46.8% below its estimated GF Value™ of A$31.49.
GuruFocus considers Ebos Group to be Significantly Undervalued.
Key valuation signals for ASX:EBO:
FCF Margin %: 0.18% (92% below median its 10-year median of 2.14)
GF Value™: A$31.49 vs. price of A$16.76 (46.8% below fair value)
Industry Position: 83% below the Medical Distribution median (#52 of 118)
No single metric tells the full story. See the ASX:EBO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ebos is the largest pharmaceutical wholesaler across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 50% and 30% of revenue, respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low-single-digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.
77GF Score
Get the complete analysis for ASX:EBO
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:EBO has been successfully added to your 
